|
TMCO3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.255000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.370050E-01 |
| Normal-vs-Stage2 |
9.923400E-01 |
| Normal-vs-Stage3 |
5.602000E-01 |
| Normal-vs-Stage4 |
1.327350E-01 |
| Stage1-vs-Stage2 |
4.669000E-01 |
| Stage1-vs-Stage3 |
8.450400E-01 |
| Stage1-vs-Stage4 |
4.462600E-01 |
| Stage2-vs-Stage3 |
6.680600E-01 |
| Stage2-vs-Stage4 |
2.223600E-01 |
| Stage3-vs-Stage4 |
4.578000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.055400E-01 |
| Normal-vs-AfricanAmerican |
7.336200E-02 |
| Normal-vs-Asian |
4.260200E-01 |
| Caucasian-vs-AfricanAmerican |
1.646620E-01 |
| Caucasian-vs-Asian |
5.011000E-01 |
| AfricanAmerican-vs-Asian |
7.537200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.311900E-02 |
| Normal-vs-Female |
2.233000E-01 |
| Male-vs-Female |
1.220120E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.753700E-02 |
| Normal-vs-Extreme_Weight |
8.438100E-03 |
| Normal-vs-Obese |
9.569200E-01 |
| Normal-vs-Extreme_Obese |
2.844400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.436600E-01 |
| Normal_Weight-vs-Obese |
1.752550E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.600400E-01 |
| Extreme_Weight-vs-Obese |
3.888400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.340400E-01 |
| Obese-vs-Extreme_Obese |
3.535400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.452200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.659600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.582000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.603900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.130800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.587400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.598200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.515820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.429780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.221800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.665000E-01 |
| Normal-VS-Type2 PRCC |
2.646500E-02 |
| Normal-VS-KIRP CIMP |
9.914200E-01 |
| Normal-VS-Unclassified PRCC |
1.816220E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.133370E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.096800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.812400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.278200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.576460E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.594800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.937600E-02 |
| Normal-vs-N1 |
5.820600E-01 |
| Normal-vs-N2 |
7.006000E-02 |
| N0-vs-N1 |
4.641400E-01 |
| N0-vs-N2 |
7.497200E-01 |
| N1-vs-N2 |
5.530400E-01 |
|
|
